Varian Medical Systems, Inc. (NYSE:VAR)
The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
secretbonus
(33.43)
Submitted: 6/24/2011 1:41:06 PM :
Start Price:
$67.85
VAR Score:
-10.19
just above fair value, but long term it's a great company. ROE, Net margins, etc
Recs
vanzweb
(< 20)
Submitted: 10/11/2010 1:13:08 PM :
Start Price:
$58.51
VAR Score:
-8.80
New top of the line product. More money pumped into health care. More people being diagnosed with cancer. Positive financial. Rock solid.
Recs
jekoslosky
(58.66)
Submitted: 8/2/2010 12:47:57 AM :
Start Price:
$55.89
VAR Score:
-4.16
Leader is advanced cancer treatment. Good growth. High margins. Little debt. Lots of cash. Up 7 % in July. Looking for pullbacks.
Recs
rpo143
(69.30)
Submitted: 6/17/2010 8:18:34 PM :
Start Price:
$52.52
VAR Score:
+2.76
treating cancer with radiotherapy, stereotactic radiosurgery, and brachytherapy.
Recs
gartersnk
(35.73)
Submitted: 12/31/2009 12:37:17 AM :
Start Price:
$47.46
VAR Score:
+17.24
radation cancer treatment, quadrix 93, oxford club rec, 5 star caps, b- street rec, buy on pullbacks
Recs
Tasm01
(40.57)
Submitted: 10/16/2009 5:17:25 PM :
Start Price:
$41.30
VAR Score:
+33.54
Technical indicators bullish
Recs
jammin200
(69.86)
Submitted: 10/10/2009 11:28:06 AM :
Start Price:
$40.18
VAR Score:
+36.41
2/122 in Health Care Equipment -(69.8@B/A)
Recs
Thleter
(92.44)
Submitted: 7/16/2009 1:28:29 PM :
Start Price:
$33.18
VAR Score:
+51.23
Just found this one recently while checking some of the top performer picks (ten mile) and really liked what I saw - even added to my real portfolio.
Recs
holopoj
(67.58)
Submitted: 7/16/2009 11:13:31 AM :
Start Price:
$33.28
VAR Score:
+49.70
Solid fundamentals. Business will pick up again after the recession
Recs
Thlete
(26.37)
Submitted: 7/14/2009 9:29:21 AM :
Start Price:
$32.56
VAR Score:
+48.86
This one caught my eye as I checked out tenmiles recent picks. I like what I'm finding while researching this company and I don't have any picks in the medical sector, so this seems like a good fit.
Recs
pp12000
(42.95)
Submitted: 6/22/2009 1:49:13 AM :
Start Price:
$36.95
VAR Score:
+27.03
obama, earnings, sales, PE
Recs
Recs
SimonSaysSell
(40.51)
Submitted: 6/10/2009 11:14:53 AM :
Start Price:
$36.90
VAR Score:
+31.28
Bandwagoning here.
Recs
Recs
snapper99man
(66.51)
Submitted: 6/2/2009 5:52:56 PM :
Start Price:
$38.11
VAR Score:
+25.48
Tenmiles
Recs
BustaCAPS
(36.45)
Submitted: 5/29/2009 4:21:20 PM :
Start Price:
$37.07
VAR Score:
+29.68
tenmile play
Recs
bobbyvee
(98.47)
Submitted: 3/7/2009 11:38:38 AM :
Start Price:
$27.39
VAR Score:
+35.17
They've been unfairly puished, and will grow as their screening products are adopted in more facilities.
Recs
mann2538
(82.89)
Submitted: 2/9/2009 4:48:26 PM :
Start Price:
$38.35
VAR Score:
+10.32
large hospital contiue to need and expand radiological services with this best in breed. Not subject to downturn in market due to necessity of products in medical communit
Recs
Cmoor
(98.78)
Submitted: 1/27/2009 11:56:52 AM :
Start Price:
$34.46
VAR Score:
+25.56
Varian is in the enviable position of having the technologically superior equipment in a business largely immune to recession. People continue to get cancer, and most receive treatment paid by third party payers. Therefore, they choose their hospital based on its reputation as being "the best". Hospital's treatment equipment is largely dictated by doctor's practicing there, and they invariably want the newest and best. Varian's sales and profit show that they continue to increase market share in the radiation treatment equipment and imaging space and that, unlike fears, purchasing of the newest and best equipment by hospitals has not slowed even during the '08 downturn. Order backlog remains high. The company has nearly $400 million in cash, little long term debt, and a history of repurchasing stock to leverage earnings per share growth. Analysts project earnings growth of 10-11% the next 4-5 years. Another quarter or two of continued earnings growth will convince the doubters this one has been oversold.
Recs
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 55 : 1 2 3 Next »